Concepedia

Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia

Daniya Sheikh, Nishita Tripathi, Thomas Chandler, Stephen Furmanek, José Bordón, Julio A. Ramírez, Rodrigo Cavallazzi

Respiratory Medicine · 2021 · 21 citations · 25 references

DOIFull text

Open access

Concepts

References

25

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.4K citations · Full text

, , +11

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Zunyou Wu, Jennifer M. McGoogan · JAMA · 2020 · 18K citations · Full text

, , +13

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

, , +15

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann, Stijn E. Verleden, Mark Kuehnel et al. · New England Journal of Medicine · 2020 · 5.9K citations · Full text

, , +17

A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia

Michael J. Fine, Thomas E. Auble, Donald M. Yealy et al. · New England Journal of Medicine · 1997 · 4.7K citations · Full text

, , +14